Reproductive health, social life and plans for the future of adolescents growing-up with HIV: a case-control study in Thailand.


Journal

AIDS care
ISSN: 1360-0451
Titre abrégé: AIDS Care
Pays: England
ID NLM: 8915313

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 4 9 2018
medline: 20 11 2019
entrez: 4 9 2018
Statut: ppublish

Résumé

Most perinatally HIV-infected children receiving antiretroviral treatment now survive into adolescence. This is a period when young people experience puberty, shape their sexual identity and initiate their own social life. The aim of our analysis was to compare aspects of the sexual and reproductive health, social life and plans for the future of perinatally HIV-infected adolescents (PHIVAs) with a control group from the general population. We used data from the Teens Living with Antiretrovirals (TEEWA) survey carried out from 2010 to 2012 in Thailand among PHIVAs aged 12-19 years. Adolescents completed a self-administered questionnaire focusing on their daily life. Each PHIVA (case) was matched on sex, age and place of residence with a randomly selected adolescent from the general population (control). Analysis was stratified by gender and age; McNemar's test was used to compare cases and controls. A total of 1142 adolescents (571 cases and 571 controls) were included in the analysis, 42% boys and 58% girls. Cases experienced puberty delay compared to controls (p < 0.01). Cases and controls did not differ in terms of sex education, sexual initiation, romantic relationships or friendships, and risky behaviours. However, PHIVAs were less likely to attend the education system (p < 0.01), to plan for marriage (p < 0.01) or parenthood (p < 0.01). PHIVAs do not differ substantially from controls in terms of sexual and social life. Yet, affirmative action policies could help counterbalance their educational handicap. Provision of psychosocial support could enhance their ability to make informed decisions with regards to family formation.

Identifiants

pubmed: 30173557
doi: 10.1080/09540121.2018.1516281
doi:

Substances chimiques

Anti-Retroviral Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

90-94

Auteurs

L Rolland-Guillard (L)

a Strasbourg University, Demographic Institute of the University of Strasbourg , Strasbourg , France.
b Institut National d'Etudes Démographiques (INED) , Paris , France.

E de La Rochebrochard (E)

b Institut National d'Etudes Démographiques (INED) , Paris , France.
c CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay , Villejuif , France.

W Sirirungsi (W)

d Faculty of Associated Medical Sciences , Chiang Mai University , Chiang Mai , Thailand.

C Kanabkaew (C)

e Institut de Recherche pour le Développement (IRD) , Chiang Mai , Thailand.

D Breton (D)

a Strasbourg University, Demographic Institute of the University of Strasbourg , Strasbourg , France.
b Institut National d'Etudes Démographiques (INED) , Paris , France.

S Le Cœur (S)

b Institut National d'Etudes Démographiques (INED) , Paris , France.
d Faculty of Associated Medical Sciences , Chiang Mai University , Chiang Mai , Thailand.
e Institut de Recherche pour le Développement (IRD) , Chiang Mai , Thailand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH